Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War) Other Current Liabilities

The latest other current liabilities for PBAXU is $16M as of June 2026. That compares with $470K in the prior-year period — up 3206.6% year over year. Investors often review this figure alongside Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, PBAXU's other current liabilities moved from $470K to $16M — a 3206.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War)'s operating scale or balance-sheet position.

A other current liabilities figure of $16M for PBAXU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PBAXU's other current liabilities ($16M), review year-over-year change from $470K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.